CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Ron Barkley, MS, JD, Cancer Center Business Development Group, is joined in this Cancer Care Business Breakthroughs video by Barry Russo, MBA, The Center for Cancer and Blood Disorders; Erich Mounce, MHA, Oncology Care Partners; Barbara McAneny, MD, New Mexico Oncology Hematology Consultants; and John Hennessy, MBA, Valuate Health Consultancy.
In a recent episode of Cancer Care Business Breakthroughs, industry experts discussed the potential implications of the formation of Risant Health, a proposed national network for value-based care by Kaiser Permanente and Geisinger Health System, on community oncology. The panelists shared their insights on the potential challenges and opportunities that this new entity could bring to the healthcare landscape.
Key Points:
- Risant Health, a combination of a provider and a health plan, is expected to focus on Medicare Advantage and bring its own health plan to the markets it enters.
- The panelists expressed concerns about increased complexity and potential barriers to patient access to oncology care due to the integration of Risant Health.
- The panelists also discussed the potential for increased patient out-of-pocket expenses and financial toxicity due to the emergence of Risant Health.
Additional Points:
- The panelists suggested that practices should educate themselves and their staff about the complexities of the market, understand how to operate in a value-based system, and demonstrate their value to integrated delivery systems.
- They also highlighted the importance of maintaining patient choice and access to care in the face of increasing consolidation in the healthcare industry.
Conclusion:
- The emergence of Risant Health could significantly impact community oncology, potentially increasing complexity and patient out-of-pocket expenses. Practices may need to adapt and demonstrate their value in order to thrive in this changing landscape.
Related Posts
“I think this is a poisonous process. I think this will eliminate or diminish the ability of patients to have a choice of an independent practice like mine or Barry’s and be able to say, ‘I would like to have a physician fee schedule practice rather than a hospital outpatient practice.'”
Dr. Barbara McAneny
CEO
New Mexico Oncology Hematology
